Sofosbuvir Plus Daclatasvir for Hepatitis C Virus Associated Cryoglobulinemia Vasculitis

被引：0
|
作者：
Saadoun, David [1 ,2 ,3 ]
Ferfar, Yasmina [1 ,2 ,3 ]
Bouyer, A. S. [1 ,2 ,3 ]
Alric, Laurent [4 ]
Hezode, Christophe [5 ]
Ahmed, S. N. Si [6 ]
Musset, L. [7 ]
Pernot, Luc De Saint Martin [8 ]
Pol, S. N. [9 ]
Larrey, Dominique [10 ]
Poynard, T. [11 ]
Cacoub, Patrice [1 ,2 ,3 ]
机构：
[1] UPMC Univ Paris 06, Sorbonne Univ, UMR 7211, F-75005 Paris, France
[2] DHU i2B, Inflammat Immunopathol Biotherapy Dept, F-75005 Paris, France
[3] Dept Internal Med & Clin Immunol, F-75013 Paris, France
[4] Toulouse 3 Univ, Ctr Hosp Univ Purpan, Dept Internal Med Digest, UMR 152, Toulouse, France
[5] Hop Henri Mondor, AP HP, Dept Hepatol, Creteil, France
[6] Hop Orleans, Dept Hepatol, Orleans, France
[7] Grp Hosp Pitie Salpetriere, AP HP, UF Immunochim & Autoimmunite, Dept Immunol, Paris, France
[8] CHRU Brest, Dept Internal Med, Brest, France
[9] Hop Cochin, AP HP, Dept Hepatol, Paris, France
[10] CHRU Montpellier, Dept Hepatol, Montpellier, France
[11] Grp Hosp Pitie Salpetriere, AP HP, Dept Hepatol, Paris, France
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17L
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Sofosbuvir Plus Ribavirin for Hepatitis C Virus Associated Cryoglobulinemia Vasculitis: Vascuvaldic Study
    Saadoun, David
    Thibault, V.
    Alric, L.
    Guillaud, C.
    Izzedine, H.
    Costopoulos, M.
    Musset, L.
    Fontaine, H.
    Hezode, C.
    Pol, S.
    Poynard, T.
    Cacoub, P.
    Ahmed, S. N. S. I.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [2] Sofosbuvir plus daclatasvir for hepatitis C virus-cryoglobulinemia vasculitis (HCV-CryoVas): VASCUVALDIC 2 Study
    Saadoun, D.
    Pol, S.
    Ferfar, Y.
    Hezode, C.
    Ahmed, S. N. S.
    Alric, L.
    de Saint Martin, L.
    Bouyer, A. S.
    Musset, L.
    Poynard, T.
    Rigon, M. R.
    Cacoub, P.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S56 - S57
  • [3] Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis
    Saadoun, David
    Pol, Stanislas
    Ferfar, Yasmina
    Alric, Laurent
    Hezode, Christophe
    Ahmed, Si Nafa Si
    Saint Martin, Luc De
    Comarmond, Cloe
    Bouyer, Anne Sophie
    Musset, Lucile
    Poynard, Thierry
    Rigon, Matthieu Resche
    Cacoub, Patrice
    [J]. GASTROENTEROLOGY, 2017, 153 (01) : 49 - +
  • [4] Evaluation of sofosbuvir plus daclatasvir combination for hepatitis C virus treatment
    Moron Romero, Rocio
    Diaz, Xando
    del Carmen Gonzalez, Maria
    Rodriguez, Alejandro
    Casas, Inmaculada
    Cabeza, Jose
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 331 - 331
  • [5] Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study
    Saadoun, David
    Thibault, Vincent
    Si Ahmed, Si Nafa
    Alric, Laurent
    Mallet, Maxime
    Guillaud, Constance
    Izzedine, Hassane
    Plaisier, Aurelie
    Fontaine, Helene
    Costopoulos, Myrto
    Le Garff-Tavernier, Magali
    Hezode, Christophe
    Pol, Stanislas
    Musset, Lucile
    Poynard, Thierry
    Cacoub, Patrice
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (10) : 1777 - 1782
  • [6] Sofosbuvir-daclatasvir improves hepatitis C virus-induced mixed cryoglobulinemia: Upper Egypt experience
    Hassan, Amro M.
    Osman, Heba A.
    Mahmoud, Hasan S.
    Hassan, Mohammed H.
    Hashim, Abdel-Kader A.
    Ameen, Hesham H.
    [J]. INFECTION AND DRUG RESISTANCE, 2018, 11 : 895 - 901
  • [7] CRYOGLOBULINEMIA WITH VASCULITIS ASSOCIATED WITH HEPATITIS-C VIRUS-INFECTION
    MARCELLIN, P
    DESCAMPS, V
    MARTINOTPEIGNOUX, M
    LARZUL, D
    XU, LZ
    BOYER, N
    PHAM, BN
    CRICKX, B
    GUILLEVIN, L
    BELAICH, S
    ERLINGER, S
    BENHAMOU, JP
    [J]. GASTROENTEROLOGY, 1993, 104 (01) : 272 - 277
  • [8] Sofosbuvir plus daclatasvir as an alternative for patients on haemodialysis with genotype 2 hepatitis C virus infection
    Llenas-Garcia, Jara
    Padilla, Sergio
    Masia, Mar
    Gutierrez, Felix
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2018, 36 (07): : 457 - 457
  • [9] Estimating the cost-effectiveness of daclatasvir plus sofosbuvir versus sofosbuvir plus ribavirin for patients with genotype 3 hepatitis C virus
    McEwan, Phil
    Webster, Samantha
    Ward, Thomas
    Brenner, Michael
    Kalsekar, Anupama
    Yuan, Yong
    [J]. COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2017, 15
  • [10] Effect of sofosbuvir plus daclatasvir for treatment of chronic hepatitis C on patients with psoriasis
    Ismail, Waleed A.
    Yousef, Ayman E.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (08) : 1025 - 1029
12345